Prelude Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-50,000
Closed -$2.55M 1800
2019
Q4
$2.55M Hold
50,000
0.1% 162
2019
Q3
$2.36M Sell
50,000
-3,000
-6% -$143K 0.11% 158
2019
Q2
$2.63M Buy
53,000
+3,000
+6% +$141K 0.13% 136
2019
Q1
$2.13M Buy
50,000
+30,000
+150% +$1.33M 0.12% 172
2018
Q4
$821K Buy
+20,000
New +$858K 0.06% 362

Other funds holding MET

Prelude Capital Management's MET Position: Q1 2026 in Review

Prelude Capital Management sold out of MetLife (MET) in Q1 2026, closing a stake of 9,672 shares — an estimated $764K sold.

Prelude Capital Management first reported a position in MET in Q1 2014 and held it in 25 quarters. The position peaked at $2.22M in Q2 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Prelude Capital Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 9,672 MetLife shares in Q1 2026, an estimated $764K.
  • Prelude Capital Management first reported a position in MetLife in Q1 2014 and held it in 25 quarters.
  • Prelude Capital Management's MetLife position peaked at $2.22M in Q2 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.